These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15530902)

  • 1. Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice.
    Espirito Santo SM; van Vlijmen BJ; van Duyvenvoorde W; Offerman EH; Havekes LM; Arnault I; Auger J; Princen HM
    Atherosclerosis; 2004 Dec; 177(2):291-7. PubMed ID: 15530902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.
    Boesten LS; Zadelaar AS; van Nieuwkoop A; Gijbels MJ; de Winther MP; Havekes LM; van Vlijmen BJ
    Cardiovasc Res; 2005 Apr; 66(1):179-85. PubMed ID: 15769461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-characterized garlic-derived materials are not hypolipidemic in APOE*3-Leiden transgenic mice.
    Espirito Santo SM; van Vlijmen BJ; Buytenhek R; van Duyvenvoorde W; Havekes LM; Arnault I; Auger J; Princen HM
    J Nutr; 2004 Jun; 134(6):1500-3. PubMed ID: 15173418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice.
    den Boer MA; Westerterp M; de Vries-van der Weij J; Wang Y; Hu L; Espirito Santo SM; Kooistra T; Reiss P; Romijn JA; Havekes LM; Rensen PC
    Atherosclerosis; 2010 Jun; 210(2):381-7. PubMed ID: 20060117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van den Maagdenberg AM; Gijbels MJ; van der Boom H; HogenEsch H; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1994 Apr; 93(4):1403-10. PubMed ID: 8163645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of fibrinogen in ApoE*3-Leiden transgenic mice does not influence the progression of diet-induced atherosclerosis.
    Rezaee F; Gijbels MJ; Offerman EH; van der Linden M; De Maat MP; Verheijen JH
    Thromb Haemost; 2002 Aug; 88(2):329-34. PubMed ID: 12195708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
    Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice.
    Ohta H; Wada H; Niwa T; Kirii H; Iwamoto N; Fujii H; Saito K; Sekikawa K; Seishima M
    Atherosclerosis; 2005 May; 180(1):11-7. PubMed ID: 15823270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
    Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice.
    Murphy N; Bruckdorfer KR; Grimsditch DC; Overend P; Vidgeon-Hart M; Groot PH; Benson GM; Graham A
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1615-20. PubMed ID: 12842836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide inhibits early atherogenesis in apoE-deficient mice.
    Chew M; Zhou J; Daugherty A; Eriksson T; Ellermann-Eriksen S; Hansen PR; Falk E
    APMIS Suppl; 2003; (109):113-6. PubMed ID: 12874961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice.
    Lardenoye JH; de Vries MR; Löwik CW; Xu Q; Dhore CR; Cleutjens JP; van Hinsbergh VW; van Bockel JH; Quax PH
    Circ Res; 2002 Oct; 91(7):577-84. PubMed ID: 12364385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van 't Hof HB; Mol MJ; van der Boom H; van der Zee A; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1996 Mar; 97(5):1184-92. PubMed ID: 8636429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice].
    Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.